Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Oct 15;194(8):1179-86.
doi: 10.1084/jem.194.8.1179.

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production

Affiliations

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production

Y Ikarashi et al. J Exp Med. .

Erratum in

  • J Exp Med 2001 Nov 5;194(9):1391

Abstract

Given the broad expression of H-2 class Ib molecules on hematopoietic cells, antigen presentation pathways among CD1d expressing cells might tightly regulate CD1d-restricted natural killer T (NKT) cells. Bone marrow-derived dendritic cells (BM-DCs) and not adherent splenocytes become capable of triggering NK1.1(+)/T cell receptor (TCR)(int) hepatic NKT cell activation when (a) immature BM-DCs lack H-2D(b)-/- molecules or (b) BM-DCs undergo a stress signal of activation. In such conditions, BM-DCs promote T helper type 1 predominant CD1d-restricted NKT cell stimulation. H-2 class Ia-mediated inhibition involves more the direct H-2D(b) presentation than the indirect Qa-1(b) pathway. Such inhibition can be overruled by B7/CD28 interactions and marginally by CD40/CD40L or interleukin 12. These data point to a unique regulatory role of DCs in NKT cell innate immune responses and suggest that H-2 class Ia and Ib pathways differentially control NKT cell recognition of DC antigens.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phenotypic analyses of ex vivo propagated BM-DCs. BM-DCs (GM-CSF plus IL-4) at day 6 (wt, left panels, and H-2Db−/−, right panels) before/or at day 7 after harvesting and transfer into new wells (wt, middle panels) were subjected to two color staining (CD11c-PE and I-Ab-FITC) or one-color staining (CD1d-PE and CD40, CD80, CD86-FITC, indirect staining for H-2Db and H-2Kb expression) and immunostained cells were analyzed in flow cytometry.
Figure 2
Figure 2
Constitutive H-2D–mediated NKT cell inhibition by immature DCs. (a) Day 6 immature BM-DCs derived from B6.wt or H-2Kb/−Db/− double KO or H-2Kb/−Db/−β2m−/−triple KO mice were cocultured at a DC/NKT cell ratio of 1:1 or 1:25 with cell sorted hepatic NK1.1+/TCRint NKT cells for 40 h. (b) Similar experiments were performed comparing BM-DCs with adherent splenocytes derived from B6. wt versus H-2Kb/−Db/− double KO versus CD1d−/− Kb/− Db/− triple KO mice cocultured with NKT cells at a DC/NKT cell ratio of 1:1 for 40 h. (c) Similar experiments were performed comparing immature day 6 BM-DCs derived from single (H-2Kb/− or H-2Db/−) KO mice versus H-2 Kb/−Db/− double KO mice (left panels). 24 and 40 h supernatants were assayed for IFN-γ in ELISA. Right panel depicts IFN-γ levels in the supernatants of NKT cells with day 6 wt BM-DCs incubated with increasing amounts of neutralizing Ab anti–H-2Db or H-2Kb. Means ± SE are depicted in all graphs. Each graph represents either pooled data from three experiments performed in duplicate wells or a representative experiment out of three. Significant differences at 95% confidence using Fisher's exact method are outlined with *. All experiments were performed with KO female mice of 6–8 wk of age after 6–8 backcrosses on C57BL/6 mice. Phenotypic features were comparable in all gene targeted BM-DCs except for H-2 or CD1d molecule expression.
Figure 2
Figure 2
Constitutive H-2D–mediated NKT cell inhibition by immature DCs. (a) Day 6 immature BM-DCs derived from B6.wt or H-2Kb/−Db/− double KO or H-2Kb/−Db/−β2m−/−triple KO mice were cocultured at a DC/NKT cell ratio of 1:1 or 1:25 with cell sorted hepatic NK1.1+/TCRint NKT cells for 40 h. (b) Similar experiments were performed comparing BM-DCs with adherent splenocytes derived from B6. wt versus H-2Kb/−Db/− double KO versus CD1d−/− Kb/− Db/− triple KO mice cocultured with NKT cells at a DC/NKT cell ratio of 1:1 for 40 h. (c) Similar experiments were performed comparing immature day 6 BM-DCs derived from single (H-2Kb/− or H-2Db/−) KO mice versus H-2 Kb/−Db/− double KO mice (left panels). 24 and 40 h supernatants were assayed for IFN-γ in ELISA. Right panel depicts IFN-γ levels in the supernatants of NKT cells with day 6 wt BM-DCs incubated with increasing amounts of neutralizing Ab anti–H-2Db or H-2Kb. Means ± SE are depicted in all graphs. Each graph represents either pooled data from three experiments performed in duplicate wells or a representative experiment out of three. Significant differences at 95% confidence using Fisher's exact method are outlined with *. All experiments were performed with KO female mice of 6–8 wk of age after 6–8 backcrosses on C57BL/6 mice. Phenotypic features were comparable in all gene targeted BM-DCs except for H-2 or CD1d molecule expression.
Figure 2
Figure 2
Constitutive H-2D–mediated NKT cell inhibition by immature DCs. (a) Day 6 immature BM-DCs derived from B6.wt or H-2Kb/−Db/− double KO or H-2Kb/−Db/−β2m−/−triple KO mice were cocultured at a DC/NKT cell ratio of 1:1 or 1:25 with cell sorted hepatic NK1.1+/TCRint NKT cells for 40 h. (b) Similar experiments were performed comparing BM-DCs with adherent splenocytes derived from B6. wt versus H-2Kb/−Db/− double KO versus CD1d−/− Kb/− Db/− triple KO mice cocultured with NKT cells at a DC/NKT cell ratio of 1:1 for 40 h. (c) Similar experiments were performed comparing immature day 6 BM-DCs derived from single (H-2Kb/− or H-2Db/−) KO mice versus H-2 Kb/−Db/− double KO mice (left panels). 24 and 40 h supernatants were assayed for IFN-γ in ELISA. Right panel depicts IFN-γ levels in the supernatants of NKT cells with day 6 wt BM-DCs incubated with increasing amounts of neutralizing Ab anti–H-2Db or H-2Kb. Means ± SE are depicted in all graphs. Each graph represents either pooled data from three experiments performed in duplicate wells or a representative experiment out of three. Significant differences at 95% confidence using Fisher's exact method are outlined with *. All experiments were performed with KO female mice of 6–8 wk of age after 6–8 backcrosses on C57BL/6 mice. Phenotypic features were comparable in all gene targeted BM-DCs except for H-2 or CD1d molecule expression.
Figure 3
Figure 3
Stress triggers DC maturation, promoting CD1d-restricted, B7-dependent NKT cell activation. (a) Day 6 immature BM-DCs pulsed or not pulsed with 10 ng/ml of α-GalCer were compared with mature day 7 BM-DCs in a coculture setting with hepatic NKT cells or T cells at a DC/NKT or T cell ratio of 1:5 for 40 h. (b) Cocultures of day 7 transferred DCs derived from B6.wt versus CD1d−/− mice with hepatic NK1.1+ TCR-βint NKT cells or hepatic NK1.1 TCR-βhigh T cells at various DC/NKT ratios were assayed for mIFN-γ (left panels) and at DC/NKT cell ratio of 1:5 for mIL-4 (right panel) using ELISA for 40 h. (c) Day 7 mature DCs were cocultured with NKT cells at a DC/NKT cell ratio of 1:5 for 24 h in the presence of 50 μg/ml of neutralizing mAb directed against mIL-12 (C17.8), mCD40L (MR1), or isotype-matched Ab or CTLA4Ig fusion proteins (left panel). Day 6 wt BM-DC were coincubated with NKT cells at a 1:5 ratio with increasing dosages of the stimulating anti-CD28 Ab PV1 plus or minus 100 IU/ml rhuIL-2 (right panel) for 48 h. Supernatants were assayed for IFN-γ in ELISA. Means ± SE are depicted in all graphs. Each graph depicts one representative experiment out of three performed in duplicate wells. Significant differences at 95% confidence using Fisher's exact method are outlined with *.
Figure 3
Figure 3
Stress triggers DC maturation, promoting CD1d-restricted, B7-dependent NKT cell activation. (a) Day 6 immature BM-DCs pulsed or not pulsed with 10 ng/ml of α-GalCer were compared with mature day 7 BM-DCs in a coculture setting with hepatic NKT cells or T cells at a DC/NKT or T cell ratio of 1:5 for 40 h. (b) Cocultures of day 7 transferred DCs derived from B6.wt versus CD1d−/− mice with hepatic NK1.1+ TCR-βint NKT cells or hepatic NK1.1 TCR-βhigh T cells at various DC/NKT ratios were assayed for mIFN-γ (left panels) and at DC/NKT cell ratio of 1:5 for mIL-4 (right panel) using ELISA for 40 h. (c) Day 7 mature DCs were cocultured with NKT cells at a DC/NKT cell ratio of 1:5 for 24 h in the presence of 50 μg/ml of neutralizing mAb directed against mIL-12 (C17.8), mCD40L (MR1), or isotype-matched Ab or CTLA4Ig fusion proteins (left panel). Day 6 wt BM-DC were coincubated with NKT cells at a 1:5 ratio with increasing dosages of the stimulating anti-CD28 Ab PV1 plus or minus 100 IU/ml rhuIL-2 (right panel) for 48 h. Supernatants were assayed for IFN-γ in ELISA. Means ± SE are depicted in all graphs. Each graph depicts one representative experiment out of three performed in duplicate wells. Significant differences at 95% confidence using Fisher's exact method are outlined with *.
Figure 3
Figure 3
Stress triggers DC maturation, promoting CD1d-restricted, B7-dependent NKT cell activation. (a) Day 6 immature BM-DCs pulsed or not pulsed with 10 ng/ml of α-GalCer were compared with mature day 7 BM-DCs in a coculture setting with hepatic NKT cells or T cells at a DC/NKT or T cell ratio of 1:5 for 40 h. (b) Cocultures of day 7 transferred DCs derived from B6.wt versus CD1d−/− mice with hepatic NK1.1+ TCR-βint NKT cells or hepatic NK1.1 TCR-βhigh T cells at various DC/NKT ratios were assayed for mIFN-γ (left panels) and at DC/NKT cell ratio of 1:5 for mIL-4 (right panel) using ELISA for 40 h. (c) Day 7 mature DCs were cocultured with NKT cells at a DC/NKT cell ratio of 1:5 for 24 h in the presence of 50 μg/ml of neutralizing mAb directed against mIL-12 (C17.8), mCD40L (MR1), or isotype-matched Ab or CTLA4Ig fusion proteins (left panel). Day 6 wt BM-DC were coincubated with NKT cells at a 1:5 ratio with increasing dosages of the stimulating anti-CD28 Ab PV1 plus or minus 100 IU/ml rhuIL-2 (right panel) for 48 h. Supernatants were assayed for IFN-γ in ELISA. Means ± SE are depicted in all graphs. Each graph depicts one representative experiment out of three performed in duplicate wells. Significant differences at 95% confidence using Fisher's exact method are outlined with *.
Figure 3
Figure 3
Stress triggers DC maturation, promoting CD1d-restricted, B7-dependent NKT cell activation. (a) Day 6 immature BM-DCs pulsed or not pulsed with 10 ng/ml of α-GalCer were compared with mature day 7 BM-DCs in a coculture setting with hepatic NKT cells or T cells at a DC/NKT or T cell ratio of 1:5 for 40 h. (b) Cocultures of day 7 transferred DCs derived from B6.wt versus CD1d−/− mice with hepatic NK1.1+ TCR-βint NKT cells or hepatic NK1.1 TCR-βhigh T cells at various DC/NKT ratios were assayed for mIFN-γ (left panels) and at DC/NKT cell ratio of 1:5 for mIL-4 (right panel) using ELISA for 40 h. (c) Day 7 mature DCs were cocultured with NKT cells at a DC/NKT cell ratio of 1:5 for 24 h in the presence of 50 μg/ml of neutralizing mAb directed against mIL-12 (C17.8), mCD40L (MR1), or isotype-matched Ab or CTLA4Ig fusion proteins (left panel). Day 6 wt BM-DC were coincubated with NKT cells at a 1:5 ratio with increasing dosages of the stimulating anti-CD28 Ab PV1 plus or minus 100 IU/ml rhuIL-2 (right panel) for 48 h. Supernatants were assayed for IFN-γ in ELISA. Means ± SE are depicted in all graphs. Each graph depicts one representative experiment out of three performed in duplicate wells. Significant differences at 95% confidence using Fisher's exact method are outlined with *.
Figure 4
Figure 4
Putative schematic representation of the DC/NKT cell cross-talk. Tissue resident DCs (immature stage) constitutively inhibit CD1d-dependent NKT cell IFN-γ production (first signal: CD1d/TCR) through a mechanism involving H-2 class I molecules (second signal: H-2D/Ly49? +/− CD94/NKG2A ?). The inhibitory pathway might be dominant because a third accessory pathway overruling the dominant negative signal is lacking on immature DCs. In contrast, after stress (LPS, transfer), DCs acquire a third accessory signal (B7/CD28) that is dominant over the second inhibitory pathway allowing CD1d-restricted DC antigen presentation. It is conceivable that in pathological conditions where high IFN-γ levels are required, DCs become capable of triggering NKT cell recognition of self and/or foreign antigens presented by MHC class Ib molecules to the canonical TCR.

Similar articles

Cited by

References

    1. Bendelac A., Riversa M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1+ T cellsdevelopment, specificity, and function. Annu. Rev. Immunol. 1997;15:535–562. - PubMed
    1. MacDonald H.R. NK1.1+ T cell receptor α/β cellsnew clues to their origin, specificity and function. J. Exp. Med. 1995;182:633–638. - PMC - PubMed
    1. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997;278:1626–1629. - PubMed
    1. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigen by human natural killer T cell. J. Exp. Med. 1998;188:1529–1534. - PMC - PubMed
    1. Burdin N., Brossay L., Koezuka Y., Smily S.T., Gurusby M., Gui M., Taniguchi M., Hayakawa K., Kronenberg M. Selective ability of mouse CD1 to present glycolipids. α-galactosylceramide specifically stimulates Vα14 NKT lymphocytes. J. Immunol. 1998;161:3271–3281. - PubMed

Publication types

MeSH terms